Frataxin Activity Quantification Using ROS Detection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods lack a reliable and accurate way to quantify the activity of Frataxin (FXN) proteins, particularly FXN fusion proteins, which are under investigation as a therapeutic for Friedreich's Ataxia, necessitating a quality control measure for manufacturing and identifying appropriate storage conditions.

Innovation Solution

A method involving combining FXN protein with a reducing agent and a reactive oxygen species (ROS) detector compound, optimized at a pH greater than 7.4 and in the absence of metal ions, to measure ROS generation, indicating enzymatic activity through increased ROS production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods are used to measure FXN activity, then the measurement process is simple, but the accuracy and reliability of quantification is insufficient

Engineering Contradiction:

Improveaccuracy of FXN activity quantificationVSAvoidcomplexity of measurement system

Core Design Contradiction:

Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces a ROS detector compound as an intermediary substance that reacts with ROS generated by FXN protein. This mediator enables indirect measurement of FXN activity through ROS detection, achieving accurate quantification without requiring direct observation of the protein's complex enzymatic action. The detector compound converts the difficult-to-measure FXN activity into an easily detectable signal.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces complex direct measurement approaches with a biochemical signaling system. Instead of attempting to directly measure FXN protein activity through complex mechanisms, the system substitutes a simplified biochemical pathway: FXN generates ROS → ROS reacts with detector compound → detectable signal is produced. This substitution dramatically simplifies the measurement process while maintaining high precision.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If FXN fusion proteins are manufactured without standardized measurement methods, then production is flexible, but quality control is insufficient

Engineering Contradiction:

Improvequality control of FXN fusion protein manufacturingVSAvoidprecision of activity quantification

Core Design Contradiction:

ReliabilityVSMeasurement precision

Solution Approach 1:

The patent establishes a feedback mechanism for quality control by providing a standardized measurement method that can be applied to each manufacturing batch. The ROS-based assay generates a quantifiable signal that reflects FXN protein activity, allowing manufacturers to feedback on batch quality and adjust production parameters accordingly. This closed-loop system ensures consistent product quality through objective, precise measurement.

Inventive Principle:

Principle #23Feedback

3Stability of the object's composition

If storage conditions for FXN fusion proteins are not systematically identified, then storage flexibility is maintained, but protein activity and stability are compromised

Engineering Contradiction:

Improvestability of FXN fusion proteinVSAvoidprecision of activity assessment

Core Design Contradiction:

Stability of the object's compositionVSMeasurement precision

Solution Approach 1:

The patent enables preliminary assessment of FXN fusion protein stability under different storage conditions before actual use. By applying the ROS-based activity assay to proteins stored under various conditions, researchers can predict which storage conditions maintain protein stability and activity. This preliminary testing allows for optimization of storage protocols to preserve protein integrity throughout storage and handling.

Inventive Principle:

Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a reliable and accurate method to quantify FXN protein activity, enabling effective quality control and identification of storage conditions, thereby ensuring the efficacy of FXN fusion proteins as a therapeutic.

Implementation Method 1

the FXN protein facilitates oxidation of the reducing agent and generation of ROS

Methodology Applied

Scientific EffectOxidation: Oxidation

Implementation Method 2

a reactive oxygen species (ROS) detector compound... measuring the amount of ROS generated

Methodology Applied

Scientific EffectROS detection:

Data Source

PatentUS12411145B2Methods for quantifying frataxin activity

Publication Date: 2025.09.09 LARIMAR THERAPEUTICS INC

AI summary

The present disclosure provides methods, compositions and kits for measuring activity of a frataxin (FXN) protein, e.g., an FXN fusion protein. The present invention also provides methods for identifying compounds capable of modulating activity of an FXN protein, e.g., an FXN fusion protein.